Видео ютуба по тегу Philip Mccarthy

Amyloidosis and immune profling in AL and ATTR amyloidosis | Philip McCarthy, MD | #ASH2025
Amyloidosis and immune profling in AL and ATTR amyloidosis | Philip McCarthy, MD | #ASH2025
"Just One Day With Us" with Dr. Philip McCarthy
Prof. Philip McCarthy, M.D. | Lenalidomide versus placebo maintenance after stem cell transplant
Prof. Philip McCarthy, M.D. | Lenalidomide versus placebo maintenance after stem cell transplant
Meet Dr. Philip McCarthy
Meet Dr. Philip McCarthy
Dr Philip McCarthy
Dr Philip McCarthy
Philip McCarthy: COSTEM highlights
Philip McCarthy: COSTEM highlights
MCRT Buffalo 2018: Myeloma Transplant and Maintenance, Dr. Philip McCarthy
MCRT Buffalo 2018: Myeloma Transplant and Maintenance, Dr. Philip McCarthy
Dr. Philip McCarthy | Welcome Message - Emirates Oncology Conference 2023
Dr. Philip McCarthy | Welcome Message - Emirates Oncology Conference 2023
MCRT Buffalo 2018: Myeloma Maintenance and Future Therapies, Dr. Philip McCarthy
MCRT Buffalo 2018: Myeloma Maintenance and Future Therapies, Dr. Philip McCarthy
Controversies in the Management of Relapsed/Refractory MM
Controversies in the Management of Relapsed/Refractory MM
A History of Stem Cell Transplantation - Philip McCarthy, MD | Round Table Buffalo, NY Sept 17, 2022
A History of Stem Cell Transplantation - Philip McCarthy, MD | Round Table Buffalo, NY Sept 17, 2022
Dr Philip McCarthy
Dr Philip McCarthy
Transplant trials in myeloma: EMN02 and BMT CTN 0702
Transplant trials in myeloma: EMN02 and BMT CTN 0702
mPatient Radio: Dr. Phillip McCarthy, Roswell Park Cancer Institute
mPatient Radio: Dr. Phillip McCarthy, Roswell Park Cancer Institute
Integrating New Therapies into the Treatment of Newly Diagnosed MM
Integrating New Therapies into the Treatment of Newly Diagnosed MM
Myeloma Crowd Radio: Dr. Philip McCarthy, Roswell Park Cancer Institute
Myeloma Crowd Radio: Dr. Philip McCarthy, Roswell Park Cancer Institute
The evolving role of maintenance therapy post-ASCT in MM
The evolving role of maintenance therapy post-ASCT in MM
Prof. Philip McCarthy | ASH 17 | Take home messages for transplant-eligible MM patients
Prof. Philip McCarthy | ASH 17 | Take home messages for transplant-eligible MM patients
What are the essential considerations in a survivorship plan for multiple myeloma?
What are the essential considerations in a survivorship plan for multiple myeloma?